Celcuity Inc. Share Price
NASDAQ: CELC | Mid CapCelcuity Inc. Stock Performance
Open $91.94 | Prev. Close $92.94 | Circuit Range N/A |
Day Range $91.94 - $95.19 | Year Range $42.54 - $151.01 | Volume 46,364 |
Average Traded $93.24 |
Celcuity Inc. Share Price Today
As of 9 August 2026, Celcuity Inc.'s share price is $93.33. The stock opened at $91.94, compared to its previous close of $92.94. During today's trading session, Celcuity Inc.'s share price traded between $91.94 and $95.19, with an average price of $93.57. Over the past 52 weeks, the stock has recorded a high of $151.01 and a low of $42.54. In terms of performance, Celcuity Inc.'s share price has declined by 16.47% over the last six months and is up 82.37% on a year-on-year basis.
Celcuity Inc. Share Price Chart
Celcuity Inc. Stock Fundamentals & Key Indicators
Market Cap $4.36B | PE Ratio (TTM) -24.63 | Dividend Yield N/A |
EPS (TTM) $-3.79 | Revenue (TTM) N/A | Return On Equity (TTM) -176.06% |
Profit Margin N/A | Debt to Equity 0.44 | Quarterly Earnings Growth YoY -47.03% |
Celcuity Inc. Quarterly Profit & Loss
All figures in USD
Celcuity Inc. Annual Profit & Loss
All figures in USD
About Celcuity Inc.
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). It also engages in developing of CELsignia diagnostic platform. The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is based in Minneapolis, Minnesota.
Celcuity Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $84.91 | $92.93 | +7.46% |
Jul 2026 | $105.78 | $86.48 | -17.41% |
Jun 2026 | $130.32 | $104.71 | -21.04% |
May 2026 | $120.75 | $132.61 | +9.27% |
Apr 2026 | $117.56 | $121.36 | +6.40% |
Mar 2026 | $110.89 | $114.06 | +2.08% |
Feb 2026 | $111.14 | $111.74 | +2.13% |
Jan 2026 | $99.71 | $109.41 | +9.80% |
Dec 2025 | $100.25 | $99.64 | -1.51% |
Nov 2025 | $77.72 | $101.17 | +31.13% |
Oct 2025 | $50.03 | $77.15 | +56.24% |
Sep 2025 | $51.60 | $49.38 | -3.52% |
CELC Share Price FAQs
What is Celcuity Inc. share price today?
What is the 52 week high and 52 week low of Celcuity Inc. stock?
What is CELC's market capitalisation today?
What is CELC's net income for the last quarter?
What is the 5 year returns of CELC?
What is the high & low stock price of CELC today?
Can I buy CELC shares in India?